1d
GlobalData on MSNThermo Fisher introduces Evos S1000 imaging system for spatial tissue proteomicsThermo Fisher Scientific has launched the Invitrogen Evos S1000 spatial imaging system, which enables researchers to produce ...
To enhance precision and efficiency in mineral processing operations, Thermo Fisher Scientific has introduced the Thermo ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Jefferies analyst Tycho Peterson has reiterated their bullish stance on TMO stock, giving a Buy rating today.Invest with Confidence: Follow ...
Goldman Sachs analyst Matthew Sykes raised the firm’s price target on Thermo Fisher (TMO) to $670 from $630 and keeps a Buy rating on the ...
Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.
Thermo Fisher is a Life Sciences giant with over $42 billion in yearly revenues and 120 thousand employees. Find out why I give TMO a contrarian sell rating.
Thermo Fisher Scientific (TMO) reported $11.4 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 4.7%. EPS of $6.10 for the same period compares to $5.67 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results